Knott David M Jr - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Knott David M Jr ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$363
-99.9%
36,0000.0%0.14%
-8.7%
Q3 2022$357,000
+1.1%
36,0000.0%0.15%
+1.4%
Q2 2022$353,0000.0%36,0000.0%0.15%
+32.1%
Q1 2022$353,000
+1.4%
36,0000.0%0.11%
-5.1%
Q4 2021$348,000–36,000–0.12%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders